Skip to main content
Top
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Multiple Myeloma | Research article

Elucidating the expression and function of Numbl during cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma (MM)

Authors: Yuejiao Huang, Xianting Huang, Chun Cheng, Xiaohong Xu, Hong Liu, Xiaojing Yang, Li Yao, Zongmei Ding, Jie Tang, Song He, Yuchan Wang

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

Cell adhesion-mediated drug resistance (CAM-DR) is a major clinical problem that prevents successful treatment of multiple myeloma (MM). In particular, the expression levels of integrin β1 and its sub-cellular distribution (internalization and trafficking) are strongly associated with CAM-DR development.

Methods

Development of an adhesion model of established MM cell lines and detection of Numbl and Integrinβ1 expression by Western Blot analysis. The interaction between Numbl and Integrinβ1 was assessed by a co-immunoprecipitation (CO-IP) method. Calcein AM assay was performed to investigate the levels of cell adhesion. Finally, the extent of CAM-DR in myeloma cells was measured using cell viability assay and flow cytometry analysis.

Results

Our preliminary date suggest that Numbl is differentially expressed in a cell adhesion model of MM cell lines. In addition to binding to the phosphotyrosine-binding (PTB) domain, the carboxyl terminal of Numbl can also interact with integrin β1 to regulate the cell cycle by activating the pro-survival PI3K/AKT signaling pathway. This study intends to verify and elucidate the interaction between Numbl and integrin β1 and its functional outcome on CAM-DR. We have designed and developed a CAM-DR model using MM cells coated with either fibronectin or bone marrow stromal cells. We assessed whether Numbl influences cell-cycle progression and whether it, in turn, contributes to activation of PI3K/AKT signal pathway through the adjustment of its carboxyl end. Finally, we showed that the interaction of Numbl with integrin β1 promotes the formation of CAM-DR in MM cells.

Conclusions

Our findings elucidated the specific molecular mechanisms of CAM-DR induction and confirmed that Numbl is crucial for the development of CAM-DR in MM cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference De P, Dey N, Terakedis B, Bergsagel PL, Li ZH, Mahadevan D. An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo. Cancer Chemother Pharmacol. 2013;71:867–81.PubMedCrossRef De P, Dey N, Terakedis B, Bergsagel PL, Li ZH, Mahadevan D. An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo. Cancer Chemother Pharmacol. 2013;71:867–81.PubMedCrossRef
2.
go back to reference Emmons MF, Gebhard AW, Nair RR, Baz R, McLaughlin ML, Cress AE. Acquisition of Resistance toward HYD1 correlates with a reduction in cleaved 4 integrin expression and a compromised CAM-DR phenotype. Mol Cancer Ther. 2011;10:2257–66.PubMedPubMedCentralCrossRef Emmons MF, Gebhard AW, Nair RR, Baz R, McLaughlin ML, Cress AE. Acquisition of Resistance toward HYD1 correlates with a reduction in cleaved 4 integrin expression and a compromised CAM-DR phenotype. Mol Cancer Ther. 2011;10:2257–66.PubMedPubMedCentralCrossRef
3.
go back to reference Fiserova B, Kubiczkova L, Sevcikova S, Hajek R. Implication of bone marrow microenvironment in pathogenesis of multiple myeloma. Klin Onkol. 2012;25:234–40.PubMed Fiserova B, Kubiczkova L, Sevcikova S, Hajek R. Implication of bone marrow microenvironment in pathogenesis of multiple myeloma. Klin Onkol. 2012;25:234–40.PubMed
4.
go back to reference Hazlehurst LA. Cell adhesion to fibronectin (CAM-DR) influences acquired Mitoxantrone resistance in U937 cells. Cancer Res. 2006;66:2338–45.PubMedCrossRef Hazlehurst LA. Cell adhesion to fibronectin (CAM-DR) influences acquired Mitoxantrone resistance in U937 cells. Cancer Res. 2006;66:2338–45.PubMedCrossRef
5.
go back to reference Lwin T, Lin J, Choi YS, Zhang X, Moscinski LC, Wright KL. Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a. Blood. 2010;116:5228–36.PubMedPubMedCentralCrossRef Lwin T, Lin J, Choi YS, Zhang X, Moscinski LC, Wright KL. Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a. Blood. 2010;116:5228–36.PubMedPubMedCentralCrossRef
6.
go back to reference Landowski TH, Olashaw NE, Agrawal D, Dalton WS. Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-κB (RelB/p50) in myeloma cells. Oncogene. 2003;22:2417–21.PubMedCrossRef Landowski TH, Olashaw NE, Agrawal D, Dalton WS. Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-κB (RelB/p50) in myeloma cells. Oncogene. 2003;22:2417–21.PubMedCrossRef
7.
go back to reference Hazlehurst LA, Dalton WS. Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies. Cancer Metastasis Rev. 2001;20:43–50.PubMedCrossRef Hazlehurst LA, Dalton WS. Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies. Cancer Metastasis Rev. 2001;20:43–50.PubMedCrossRef
8.
go back to reference Damiano JS, Hazlehurst LA, Dalton WS. Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation. Leukemia. 2001;15:1232.PubMedCrossRef Damiano JS, Hazlehurst LA, Dalton WS. Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation. Leukemia. 2001;15:1232.PubMedCrossRef
9.
go back to reference Arnaout MA, Goodman SL, Xiong JP. Coming to grips with integrin binding to ligands. Curr Opin Cell Biol. 2002;14:641–51.PubMedCrossRef Arnaout MA, Goodman SL, Xiong JP. Coming to grips with integrin binding to ligands. Curr Opin Cell Biol. 2002;14:641–51.PubMedCrossRef
10.
go back to reference Berry MG, Goode AW, Puddefoot JR, Vinson GP, Carpenter R. Integrin beta1-mediated invasion of human breast cancer cells: an ex vivo assay for invasiveness. Breast cancer (Tokyo, Japan). 2003;10:214.CrossRef Berry MG, Goode AW, Puddefoot JR, Vinson GP, Carpenter R. Integrin beta1-mediated invasion of human breast cancer cells: an ex vivo assay for invasiveness. Breast cancer (Tokyo, Japan). 2003;10:214.CrossRef
11.
go back to reference Oshita F, Kameda Y, Hamanaka N, Saito H, Yamada K, Noda K. High expression of integrin beta1 and p53 is a greater poor prognostic factor than clinical stage in small-cell lung cancer. Am J Clin Oncol. 2004;27:215–9.PubMedCrossRef Oshita F, Kameda Y, Hamanaka N, Saito H, Yamada K, Noda K. High expression of integrin beta1 and p53 is a greater poor prognostic factor than clinical stage in small-cell lung cancer. Am J Clin Oncol. 2004;27:215–9.PubMedCrossRef
12.
go back to reference Ke JJ, Shao QS, Ling ZQ. Expression of E-selectin, integrin beta1 and immunoglobulin superfamily member in human gastric carcinoma cells and its clinicopathologic significance. World J Gastroenterol. 2006;12:3609–11.PubMedPubMedCentralCrossRef Ke JJ, Shao QS, Ling ZQ. Expression of E-selectin, integrin beta1 and immunoglobulin superfamily member in human gastric carcinoma cells and its clinicopathologic significance. World J Gastroenterol. 2006;12:3609–11.PubMedPubMedCentralCrossRef
13.
go back to reference Hazlehurst LA, Argilagos RF, Dalton WS. Beta1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells. Br J Haematol. 2007;136:269–75.PubMedCrossRef Hazlehurst LA, Argilagos RF, Dalton WS. Beta1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells. Br J Haematol. 2007;136:269–75.PubMedCrossRef
14.
go back to reference Guo-Bao W, Xiao-Qin C, Qi-Rong G, Jie L, Gui-Nan L. Yue, L arsenic trioxide overcomes cell adhesion-mediated drug resistance through down-regulating the expression of β. Leuk Lymphoma. 2010;51:1090–7.PubMedCrossRef Guo-Bao W, Xiao-Qin C, Qi-Rong G, Jie L, Gui-Nan L. Yue, L arsenic trioxide overcomes cell adhesion-mediated drug resistance through down-regulating the expression of β. Leuk Lymphoma. 2010;51:1090–7.PubMedCrossRef
15.
go back to reference Naci D, El Azreq MA, Chetoui N, Lauden L, Sigaux F, Charron D. 2 1 integrin promotes Chemoresistance against doxorubicin in cancer cells through extracellular signal-regulated kinase (ERK). J Biol Chem. 2012;287:17065–76.PubMedPubMedCentralCrossRef Naci D, El Azreq MA, Chetoui N, Lauden L, Sigaux F, Charron D. 2 1 integrin promotes Chemoresistance against doxorubicin in cancer cells through extracellular signal-regulated kinase (ERK). J Biol Chem. 2012;287:17065–76.PubMedPubMedCentralCrossRef
16.
go back to reference Terol MJ, Lopez-Guillermo A, Bosch F, Villamor N, Cid MC, Campo E. Expression of beta-integrin adhesion molecules in non-Hodgkin's lymphoma: correlation with clinical and evolutive features. J Clin Oncol. 1999;17:1869–75.PubMedCrossRef Terol MJ, Lopez-Guillermo A, Bosch F, Villamor N, Cid MC, Campo E. Expression of beta-integrin adhesion molecules in non-Hodgkin's lymphoma: correlation with clinical and evolutive features. J Clin Oncol. 1999;17:1869–75.PubMedCrossRef
17.
18.
go back to reference Caswell PT, Norman JC. Integrin trafficking and the control of cell migration. Traffic. 2006;7:14–21.PubMedCrossRef Caswell PT, Norman JC. Integrin trafficking and the control of cell migration. Traffic. 2006;7:14–21.PubMedCrossRef
19.
go back to reference Riggs KA, Hasan N, Humphrey D, Raleigh C, Nevitt C, Corbin D. Regulation of integrin endocytic recycling and chemotactic cell migration by syntaxin 6 and VAMP3 interaction. J Cell Sci. 2012;125:3827–39.PubMedPubMedCentralCrossRef Riggs KA, Hasan N, Humphrey D, Raleigh C, Nevitt C, Corbin D. Regulation of integrin endocytic recycling and chemotactic cell migration by syntaxin 6 and VAMP3 interaction. J Cell Sci. 2012;125:3827–39.PubMedPubMedCentralCrossRef
20.
go back to reference Tringali C, Lupo B, Silvestri I, Papini N, Anastasia L, Tettamanti G. The plasma membrane Sialidase NEU3 regulates the malignancy of renal carcinoma cells by controlling 1 integrin internalization and recycling. J Biol Chem. 2012;287:42835–45.PubMedPubMedCentralCrossRef Tringali C, Lupo B, Silvestri I, Papini N, Anastasia L, Tettamanti G. The plasma membrane Sialidase NEU3 regulates the malignancy of renal carcinoma cells by controlling 1 integrin internalization and recycling. J Biol Chem. 2012;287:42835–45.PubMedPubMedCentralCrossRef
21.
go back to reference Lobert VH, Brech A, Pedersen NM, Wesche J, Oppelt A, Malerød L. Ubiquitination of α5integrin β1 controls fibroblast migration through lysosomal degradation of fibronectin-integrin complexes. Dev Cell. 2010 Elsevier Inc. All rights reserved. 2010;19:148–59.PubMedCrossRef Lobert VH, Brech A, Pedersen NM, Wesche J, Oppelt A, Malerød L. Ubiquitination of α5integrin β1 controls fibroblast migration through lysosomal degradation of fibronectin-integrin complexes. Dev Cell. 2010 Elsevier Inc. All rights reserved. 2010;19:148–59.PubMedCrossRef
22.
go back to reference Nishimura T, Kaibuchi K. Numb controls integrin endocytosis for directional cell migration with aPKC and PAR-3. Dev Cell. 2007;13:15–28.PubMedCrossRef Nishimura T, Kaibuchi K. Numb controls integrin endocytosis for directional cell migration with aPKC and PAR-3. Dev Cell. 2007;13:15–28.PubMedCrossRef
23.
go back to reference Rašin M, Gazula V, Breunig JJ, Kwan KY, Johnson MB, Liu-Chen S. Numb and Numbl are required for maintenance of cadherin-based adhesion and polarity of neural progenitors. Nat Neurosci. 2007;10:819–27.PubMedCrossRef Rašin M, Gazula V, Breunig JJ, Kwan KY, Johnson MB, Liu-Chen S. Numb and Numbl are required for maintenance of cadherin-based adhesion and polarity of neural progenitors. Nat Neurosci. 2007;10:819–27.PubMedCrossRef
24.
go back to reference Zhong W, Feder JN, Jiang M, Jan LY, Jan YN. Asymmetric localization of a mammalian numb homolog during mouse cortical neurogenesis. Neuron. 1996;17:43–53.PubMedCrossRef Zhong W, Feder JN, Jiang M, Jan LY, Jan YN. Asymmetric localization of a mammalian numb homolog during mouse cortical neurogenesis. Neuron. 1996;17:43–53.PubMedCrossRef
25.
go back to reference Bogdanović O, Delfino-Machín M, Nicolás-Pérez M, Gavilán MP, Gago-Rodrigues I, Fernández-Miñán A. Numb/Numbl-Opo antagonism controls retinal epithelium morphogenesis by regulating integrin endocytosis. Dev CellCopyright (c) 2012 Elsevier Inc. All rights reserved. 2012;23:782–95.PubMedCrossRef Bogdanović O, Delfino-Machín M, Nicolás-Pérez M, Gavilán MP, Gago-Rodrigues I, Fernández-Miñán A. Numb/Numbl-Opo antagonism controls retinal epithelium morphogenesis by regulating integrin endocytosis. Dev CellCopyright (c) 2012 Elsevier Inc. All rights reserved. 2012;23:782–95.PubMedCrossRef
27.
go back to reference Zhang J, Chen F, Li W, Xiong Q, Yang M, Zheng P. 14–3-3ζ interacts with Stat3 and regulates its constitutive activation in multiple myeloma cells. PLoS One. 2012;7:e29554.PubMedPubMedCentralCrossRef Zhang J, Chen F, Li W, Xiong Q, Yang M, Zheng P. 14–3-3ζ interacts with Stat3 and regulates its constitutive activation in multiple myeloma cells. PLoS One. 2012;7:e29554.PubMedPubMedCentralCrossRef
28.
go back to reference Hazlehurst LA, Damiano JS, Buyuksal I, Pledger WJ, Dalton WS. Adhesion to fibronectin via integrin β1s regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). Oncogene. 2000;19:4319–27.PubMedCrossRef Hazlehurst LA, Damiano JS, Buyuksal I, Pledger WJ, Dalton WS. Adhesion to fibronectin via integrin β1s regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). Oncogene. 2000;19:4319–27.PubMedCrossRef
29.
go back to reference Lwin T, Hazlehurst LA, Dessureault S, Lai R, Bai W, Sotomayor E. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas. Blood. 2007;110:1631–8.PubMedPubMedCentralCrossRef Lwin T, Hazlehurst LA, Dessureault S, Lai R, Bai W, Sotomayor E. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas. Blood. 2007;110:1631–8.PubMedPubMedCentralCrossRef
30.
go back to reference Meads MB, Hazlehurst LA, Dalton WS. The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance. Clin Cancer Res. 2008;14:2519–26.PubMedCrossRef Meads MB, Hazlehurst LA, Dalton WS. The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance. Clin Cancer Res. 2008;14:2519–26.PubMedCrossRef
31.
go back to reference Lee JW, Juliano R. Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways. Mol Cells. 2004;17:188.PubMed Lee JW, Juliano R. Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways. Mol Cells. 2004;17:188.PubMed
34.
go back to reference Hehlgans S, Haase M, Cordes N. Signalling via integrins: implications for cell survival and anticancer strategies. Biochimica et Biophysica Acta (BBA)Reviews on Cancer. 2007;1775:163–80. Hehlgans S, Haase M, Cordes N. Signalling via integrins: implications for cell survival and anticancer strategies. Biochimica et Biophysica Acta (BBA)Reviews on Cancer. 2007;1775:163–80.
35.
go back to reference Meads MB, Gatenby RA, Dalton WS. Environment-mediated drug resistance: a major contributor to minimal residual disease. Nat Rev Cancer. 2009;9:665–74.PubMedCrossRef Meads MB, Gatenby RA, Dalton WS. Environment-mediated drug resistance: a major contributor to minimal residual disease. Nat Rev Cancer. 2009;9:665–74.PubMedCrossRef
36.
go back to reference Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS. Cell adhesion mediated drug resistance (CAM-DR): role of Integrins and resistance to apoptosis in human myeloma cell lines. Blood. 1999;93:1658.PubMedCrossRef Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS. Cell adhesion mediated drug resistance (CAM-DR): role of Integrins and resistance to apoptosis in human myeloma cell lines. Blood. 1999;93:1658.PubMedCrossRef
37.
go back to reference Barda-Saad M, Zhang AS, Zipori D, Rozenszajn LA. Adhesion of Thymocytes to bone marrow stromal cells: regulation by bFGF and IFN-γ. Stem Cells. 1997;15(3):229–36.PubMedCrossRef Barda-Saad M, Zhang AS, Zipori D, Rozenszajn LA. Adhesion of Thymocytes to bone marrow stromal cells: regulation by bFGF and IFN-γ. Stem Cells. 1997;15(3):229–36.PubMedCrossRef
38.
go back to reference Akeson A, Woods C. A fluorometric assay for the quantitation of cell adherence to endothelial cells. J Immunol Methods. 1993;163:181–5.PubMedCrossRef Akeson A, Woods C. A fluorometric assay for the quantitation of cell adherence to endothelial cells. J Immunol Methods. 1993;163:181–5.PubMedCrossRef
39.
go back to reference Wang Y, Huang Y, Xu X, Tang J, Huang X. Expression of small glutamine-rich TPR-containing protein a (SGTA) in non-Hodgkin's lymphomas promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR). Leuk Res. 2014 Aug;38(8):955–63.PubMedCrossRef Wang Y, Huang Y, Xu X, Tang J, Huang X. Expression of small glutamine-rich TPR-containing protein a (SGTA) in non-Hodgkin's lymphomas promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR). Leuk Res. 2014 Aug;38(8):955–63.PubMedCrossRef
40.
go back to reference Guan JL. Role of focal adhesion kinase in integrin signaling. Int J Biochem Cell Biol. 1997;29:1085–96.PubMedCrossRef Guan JL. Role of focal adhesion kinase in integrin signaling. Int J Biochem Cell Biol. 1997;29:1085–96.PubMedCrossRef
41.
go back to reference Oellerich T, Oellerich MF, Engelke M, Munch S, Mohr S. beta2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis. Blood. 2013;121:3889–99 S3881-3866.PubMedCrossRef Oellerich T, Oellerich MF, Engelke M, Munch S, Mohr S. beta2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis. Blood. 2013;121:3889–99 S3881-3866.PubMedCrossRef
42.
go back to reference Rajkumar V, Kumar S. Multiple myeloma: diagnosis and treatment. Mayo Clin Proc. 2016;91(1):101–19.PubMedCrossRef Rajkumar V, Kumar S. Multiple myeloma: diagnosis and treatment. Mayo Clin Proc. 2016;91(1):101–19.PubMedCrossRef
43.
go back to reference Lee S, Cho H, Na G, Yoo MR, Seo S, Hur DY. CD40 stimulation induces vincristine resistance via AKT activation and MRP1 expression in a human multiple myeloma cell line. Immunol LettCopyright (c) 2012 Elsevier B.V. All rights reserved. 2012;144:41–8.PubMedCrossRef Lee S, Cho H, Na G, Yoo MR, Seo S, Hur DY. CD40 stimulation induces vincristine resistance via AKT activation and MRP1 expression in a human multiple myeloma cell line. Immunol LettCopyright (c) 2012 Elsevier B.V. All rights reserved. 2012;144:41–8.PubMedCrossRef
44.
45.
go back to reference Zheng Y, Yang J, Qian J, Qiu P, Hanabuchi S, Lu Y. PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma. Leukemia. 2012;27:702–10.PubMedPubMedCentralCrossRef Zheng Y, Yang J, Qian J, Qiu P, Hanabuchi S, Lu Y. PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma. Leukemia. 2012;27:702–10.PubMedPubMedCentralCrossRef
46.
go back to reference Balakumaran A, Robey PG, Fedarko N, Landgren O. Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis. Expert Rev Mol Diagn. 2010;10:465–80.PubMedPubMedCentralCrossRef Balakumaran A, Robey PG, Fedarko N, Landgren O. Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis. Expert Rev Mol Diagn. 2010;10:465–80.PubMedPubMedCentralCrossRef
47.
go back to reference Yanamandra N. Tipifarnib and Bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia. Clin Cancer Res. 2006;12:591–9.PubMedCrossRef Yanamandra N. Tipifarnib and Bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia. Clin Cancer Res. 2006;12:591–9.PubMedCrossRef
48.
go back to reference Kurtova A, Balakrishnan K, Chen R, Ding W, Schnabl S, Quiroga M. Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood. 2009;114:4441–50.PubMedPubMedCentralCrossRef Kurtova A, Balakrishnan K, Chen R, Ding W, Schnabl S, Quiroga M. Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood. 2009;114:4441–50.PubMedPubMedCentralCrossRef
49.
go back to reference Yingjie L, Jian T, Changhai Y, Jingbo L. Numblike regulates proliferation, apoptosis, and invasion of lung cancer cell. Tumor Biol. 2013;34:2773–80.CrossRef Yingjie L, Jian T, Changhai Y, Jingbo L. Numblike regulates proliferation, apoptosis, and invasion of lung cancer cell. Tumor Biol. 2013;34:2773–80.CrossRef
50.
go back to reference Tao T, Cheng C, Ji Y, Xu G, Zhang J, Zhang L. Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF- B activation. Mol Biol Cell. 2012;23:2635–44.PubMedPubMedCentralCrossRef Tao T, Cheng C, Ji Y, Xu G, Zhang J, Zhang L. Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF- B activation. Mol Biol Cell. 2012;23:2635–44.PubMedPubMedCentralCrossRef
51.
go back to reference Bloma T, Rosellia A, Tannerb M, Nupponena N. Mutation and copy number analysis of LNX1 and Numbl in nervous system tumors. Cancer Genet Cytogenet. 2008;186(2):103–9.CrossRef Bloma T, Rosellia A, Tannerb M, Nupponena N. Mutation and copy number analysis of LNX1 and Numbl in nervous system tumors. Cancer Genet Cytogenet. 2008;186(2):103–9.CrossRef
52.
go back to reference Nwaeburu C, Bauer N, Zhao Z, Abukiwan A, Gladkich J, Benner A. Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl. Oncotarget. 2016;7(36):58367–80.PubMedPubMedCentralCrossRef Nwaeburu C, Bauer N, Zhao Z, Abukiwan A, Gladkich J, Benner A. Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl. Oncotarget. 2016;7(36):58367–80.PubMedPubMedCentralCrossRef
53.
go back to reference Liang L, Fan Y, Dandan Z, Meng L, Xiaodong L. Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3. Oncotarget. 2016;7(9):9844–58.PubMedPubMedCentral Liang L, Fan Y, Dandan Z, Meng L, Xiaodong L. Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3. Oncotarget. 2016;7(9):9844–58.PubMedPubMedCentral
54.
go back to reference Liang L, Xinwei Z, Li C, Quanming A, Jie H. Reelin promotes adhesion of multiple myeloma cells to bone marrow stromal cells via integrin β1 signaling. J Cancer. 2017;8(12):2212–22.CrossRef Liang L, Xinwei Z, Li C, Quanming A, Jie H. Reelin promotes adhesion of multiple myeloma cells to bone marrow stromal cells via integrin β1 signaling. J Cancer. 2017;8(12):2212–22.CrossRef
Metadata
Title
Elucidating the expression and function of Numbl during cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma (MM)
Authors
Yuejiao Huang
Xianting Huang
Chun Cheng
Xiaohong Xu
Hong Liu
Xiaojing Yang
Li Yao
Zongmei Ding
Jie Tang
Song He
Yuchan Wang
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-6446-y

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine